top of page
06 THE DAILY EPISODE What vaccine makers have to say about the omicron vaccine Wednesday, December 1, 2021 New Delhi The World Suu Kyi's incitement trial verdict delayed by Myanmar court: report The Daily Episode Network A source close to the case told AFP that the Myanmar junta has delayed giving its verdict in the incitement trial of ousted civilian leader Aung San Suu Kyi. A source told the Associated Press that the court, which was set to rule on her trial for incitement against the military, has adjourned the verdict "until December 6." Shouldn't panic, but will act as more science emerges: Anthony Fauci Shiksha Dev | The DEN Joe Biden's chief medical adviser, Dr Anthony Fauci, reiterated the president's position and advocated vaccination against Coronavirus disease (Covid-19) even as the world scrambled to introduce more preventive measures to halt the surge in cases due to the new variant. Changi airport hosted two travellers bound for Sydney with Omicron Shiksha Dev | The DEN Two travellers from Johannesburg who tested positive for the Omicron coronavirus variant in Sydney had transited through Changi airport, according to Singapore's health ministry. Singapore Airlines flew the two individuals from Johannesburg to Changi on Nov. 27 for their transit flight, according to the ministry. Their Covid-19 tests were negative before departure, the ministry said. Parg Agrawal is S&P 500's youngest CEO The Daily Episode Network Agrawal, who succeeds Twitter's founder and CEO Jack Dorsey, will become the youngest CEO in the S&P 500, beating Meta Platform Inc.'s Mark Zuckerberg. Mark Zuckerberg and Agrawal are both 37 years old. Due to security concerns, Twitter has not disclosed Agrawal's date of birth What vaccine makers have to say about the omicron vaccine The Daily Episode Network Albert Bourla, Pfizer's CEO, has revealed that the company has already started developing a version of its Covid-19 vaccine that targets the new variant of Omicron. Another leading Covid-19 vaccine maker, Moderna Inc, has announced it will develop a booster shot against the new variant.
bottom of page